Nycomed optimises its European manufacturing network
- Details
- Category: Nycomed
![Nycomed Nycomed](http://www.worldpharmanews.com/images/stories/logo/nycomed.gif)
Pfizer Launches New Medicine Safety Website for Healthcare Professionals and Patients
- Details
- Category: Pfizer
![Pfizer Inc Pfizer Inc](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
Novo Nordisk acquires intellectual property rights from Neose Technologies
- Details
- Category: Novo Nordisk
![Novo Nordisk Novo Nordisk](http://www.worldpharmanews.com/images/stories/logo/novonordisk_b.gif)
Bayer HealthCare acquires German DIREVO Biotech AG
- Details
- Category: Bayer
![The Bayer Group The Bayer Group](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
DHL COLDCHAIN offers fast, reliable and flexible solutions designed for the Life Science Industry
- Details
- Category: Business
The life science industry increasingly demands for Europe-wide transport solutions which are able to guarantee product integrity. Being able to offer this, strengthens a global market position. Thus, DHL Freight has been developing the unique DHL COLDCHAIN network.
Bayer Intensifies Research in Early Diagnosis of Alzheimer's Disease
- Details
- Category: Bayer
![Bayer AG Bayer AG](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
Pfizer Will Withdraw Global Marketing Applications for Dalbavancin to Conduct a New Trial
- Details
- Category: Pfizer
![Pfizer Inc Pfizer Inc](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
More Pharma News ...
- New low-dose oral contraceptive YAZ® launched in Europe
- Novo Nordisk launches a next generation of FlexPen®
- Pfizer and Medivation Enter into Global Agreement to Co-Develop and Market Dimebon
- TRANSCEND® trial confirms long-term protective benefits and excellent tolerability profile
- Anavex completes successful preclinical studies on lead Alzheimer's drug candidate
- Novartis decides not to pursue further development of Aurograb(TM)
- Rivaroxaban Phase II Data in ACS to be Presented at AHA Congress in November